EVOLET - About the company
EVOLET is an unfunded company based in Gurugram (India), founded in 1991 by Aman Preet Kaur, Zafarkhon Mirzoev and Sadullo Abdulloev. It operates as a Pharmaceutical company offers distribution, marketing, outsourcing, and manufacturing of pharmaceutical products. EVOLET has not raised any funding yet. The company has 369 active competitors, including 40 funded and 54 that have exited. Its top competitors include companies like Novartis, Catalent and Biotage.
Company Details
Pharmaceutical company offers distribution, marketing, outsourcing, and manufacturing of pharmaceutical products. It specializes in producing tablets, capsules, ointments, and liquids across various therapeutic segments. It manufactures pharmaceutical products across a wide range of therapeutic segments, including Analgesics, Antacids, Antiemetics, Antiulcer, Antispasmodics, Antimalarials, Antiepileptics, Cardiac & Diabetic care, Hematics, and more.
- Website
- evolet.in
- Social
- Email ID
- *****@evolet.in
- Phone Number
- +91 **********
- Registered Address
- 1101-1108, 11th Floor, Imperia Mindspace, Golf Course Extension Road, Near Village Maidawas, Sector 62, Bhorakalan, Gurgaon, Bhorakalan, Haryana, India, 122413
Key Metrics
Founded Year
1991
Location
Gurugram, India
Stage
Unfunded
Ranked
128th among 369 active competitors
Annual Revenue
₹100 - ₹500 Cr as on Mar 31, 2025
Employee Count
51 as on Jan 31, 2025
Legal entities associated with EVOLET
EVOLET is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
EVOLET PHARMA SOLUTIONS PRIVATE LIMITED CIN: U74990DL2018PTC343117 , India, Strike off | Dec 17, 2018 | 0 - ₹10 Cr (As on Mar 31, 2023) | - | |
Evolet Healthcare Private Limited CIN: U33100HR2011PTC127250 , India, Active | Feb 07, 2011 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 51 (As on Jan 31, 2025) | |
EVOLET PRIVATE LIMITED CIN: U74999HR2017PTC127342 , India, Active | Apr 28, 2017 | 0 - ₹10 Cr (As on Mar 31, 2025) | - |
Sign up to download EVOLET's company profile
EVOLET's funding and investors
EVOLET has not raised any funding rounds yet.
EVOLET's founders and board of directors
Founder? Claim ProfileHere are the details of EVOLET's key team members:
- Aman Preet Kaur: Co-Owner of EVOLET.
- Zafarkhon Mirzoev: Co-Owner of EVOLET.
- Sadullo Abdulloev: Co-Owner & CFO of EVOLET. Contact Info: 1 email address and 1 phone number
View details of EVOLET's Founder profiles and Board Members
EVOLET's employee count trend
EVOLET has 51 employees as of Jan 25. The total employee count is the same as what it was in Jan 24. Here is EVOLET's employee count trend over the years:
Uncover EVOLET's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
EVOLET's Competitors and alternates
Top competitors of EVOLET include Novartis, Catalent and Biotage. Here is the list of Top 10 competitors of EVOLET, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Novartis 1996, Basel (Switzerland), Public | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 70/100 | |
2nd | Catalent 2007, Somerset (United States), Acquired | Provider of development, manufacturing, and packaging solutions for medicines and supplements | - | 68/100 | |
3rd | Organic synthesis, analytical, and peptide chemistry services for drug discovery and development | - | 64/100 | ||
4th | Tirupati Medicare 1980, Paonta Sahib (India), Series B | Contract manufacturer of pharmaceutical products | $51.5M | 59/100 | |
5th | Surrozen 2016, San Francisco (United States), Public | Pioneering targeted regenerative antibodies to repair tissue and restore organ function | $133M | 59/100 | |
6th | BioFactura 2004, Frederick (United States), Series B | Biosimilars, biodefense, and biomanufacturing company dedicated to innovation and global biomedical needs | $7.8M | 56/100 | |
7th | Biofortuna 2008, Birkenhead (United Kingdom), Series A | Provider of manufacturing services for immunoassays, molecular diagnostics, and regulatory services | $21.6M | 55/100 | |
8th |  Acclinate 2020, Birmingham (United States), Series A | Provider of clinical trial services to biopharma sector | $15.5M | 55/100 | |
9th |  AmplifyBio 2021, Hilliard (United States), Deadpooled | Provider of contract research, development, and manufacturing services for biologic drugs | $230M | 53/100 | |
10th | Sunflower Therapeutics 2018, Hingham (United States), Series A | Provider of drug development & research services for multiple therapeutic areas | $5.64M | 52/100 | |
128th | Pharmaceutical company offers distribution, marketing, outsourcing, and manufacturing of pharmaceutical products | - | - | 23/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on EVOLET's competitors? Click here to see the top ones
EVOLET's Investments and acquisitions
EVOLET has made no investments or acquisitions yet.
News related to EVOLET
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about EVOLET
Explore our recently published companies
- Wildlandservices - Auburn based, 2009 founded, Unfunded company
- Boninogroup - 1979 founded, Funding Raised company
- Techlib - India based, 2011 founded, Unfunded company
